NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 199 filers reported holding NEKTAR THERAPEUTICS in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $46,076,000 | -20.0% | 3,755,197 | +12.0% | 0.01% | -22.2% |
Q3 2016 | $57,615,000 | +23.0% | 3,353,625 | +1.9% | 0.01% | +12.5% |
Q2 2016 | $46,841,000 | +4.1% | 3,291,707 | +0.6% | 0.01% | +14.3% |
Q1 2016 | $44,976,000 | -19.0% | 3,270,963 | -0.7% | 0.01% | -22.2% |
Q4 2015 | $55,522,000 | +59.6% | 3,295,092 | +3.8% | 0.01% | +50.0% |
Q3 2015 | $34,780,000 | -13.5% | 3,173,347 | -1.3% | 0.01% | 0.0% |
Q2 2015 | $40,220,000 | -16.2% | 3,215,004 | -26.4% | 0.01% | -14.3% |
Q1 2015 | $48,022,000 | -9.0% | 4,365,679 | +28.2% | 0.01% | -12.5% |
Q4 2014 | $52,774,000 | +26.6% | 3,404,803 | -1.4% | 0.01% | +14.3% |
Q3 2014 | $41,680,000 | -7.9% | 3,453,213 | -2.2% | 0.01% | -12.5% |
Q2 2014 | $45,249,000 | +4.8% | 3,529,562 | -0.9% | 0.01% | +14.3% |
Q1 2014 | $43,183,000 | +19.4% | 3,562,948 | +11.8% | 0.01% | +16.7% |
Q4 2013 | $36,179,000 | +6.0% | 3,187,568 | -2.5% | 0.01% | -14.3% |
Q3 2013 | $34,142,000 | -10.1% | 3,268,704 | -0.5% | 0.01% | -12.5% |
Q2 2013 | $37,958,000 | – | 3,286,442 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |